Axel Lipp1, Cornelia Skowronek1, Andreas Fehlner2, Kaspar-Josche Streitberger1, Jürgen Braun3, Ingolf Sack4. 1. Department of Neurology, Charité - University Medicine Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. 2. Department of Radiology, Charité - University Medicine Berlin, Charitéplatz 1, 10117, Berlin, Germany. 3. Institute of Medical Informatics, Charité - University Medicine Berlin, Charitéplatz 1, 10117, Berlin, Germany. 4. Department of Radiology, Charité - University Medicine Berlin, Charitéplatz 1, 10117, Berlin, Germany. ingolf.sack@charite.de.
Abstract
OBJECTIVES: To apply three-dimensional multifrequency MR-elastography (3DMRE) for the measurement of local cerebral viscoelasticity changes in patients with Parkinson's disease (PD) and progressive supranuclear palsy (PSP). METHODS: T1-weighted anatomical imaging and 3DMRE were performed in 17 PD and 20 PSP patients as well as 12 controls. Two independent viscoelasticity parameters, |G*| and φ, were reconstructed combining seven harmonic vibration frequencies (30-60 Hz). Spatially averaged values were compared by one-way ANOVA, groups were compared using unpaired t test and Mann-Whitney test, respectively. Correlation between clinical data and parameters of brain elasticity and volume were calculated by Pearson's correlation coefficient. RESULTS: In patients, |G*| was significantly reduced in the frontal and mesencephalic regions (p < 0.05). Beyond that, reduced mesencephalic |G*| discriminated PSP from PD (p < 0.05). Neurodegeneration causes significant brain atrophy (p < 0.01) and is pronounced in PSP patients (p < 0.05 vs. PD). Reduced brain viscoelasticity is correlated with brain atrophy in PSP (r=0.64, p=0.002) and PD (r=0.65, p=0.005) patients but not in controls. CONCLUSIONS: MRE-measured viscoelasticity reflects local structural changes of brain tissue in PSP and in PD and provides a useful parameter to differentiate neurodegenerative movement disorders based on imaging examinations. KEY POINTS: • 3D multifrequency MR-elastography reveals diffuse regional changes in brain viscoelasticity in neurodegenerative disorders. • Reduced mesencephalic viscoelasticity separates PD and PSP. • Reduced brain viscoelasticity and brain atrophy as independent hallmarks of neurodegeneration hypothesized.
OBJECTIVES: To apply three-dimensional multifrequency MR-elastography (3DMRE) for the measurement of local cerebral viscoelasticity changes in patients with Parkinson's disease (PD) and progressive supranuclear palsy (PSP). METHODS: T1-weighted anatomical imaging and 3DMRE were performed in 17 PD and 20 PSPpatients as well as 12 controls. Two independent viscoelasticity parameters, |G*| and φ, were reconstructed combining seven harmonic vibration frequencies (30-60 Hz). Spatially averaged values were compared by one-way ANOVA, groups were compared using unpaired t test and Mann-Whitney test, respectively. Correlation between clinical data and parameters of brain elasticity and volume were calculated by Pearson's correlation coefficient. RESULTS: In patients, |G*| was significantly reduced in the frontal and mesencephalic regions (p < 0.05). Beyond that, reduced mesencephalic |G*| discriminated PSP from PD (p < 0.05). Neurodegeneration causes significant brain atrophy (p < 0.01) and is pronounced in PSPpatients (p < 0.05 vs. PD). Reduced brain viscoelasticity is correlated with brain atrophy in PSP (r=0.64, p=0.002) and PD (r=0.65, p=0.005) patients but not in controls. CONCLUSIONS: MRE-measured viscoelasticity reflects local structural changes of brain tissue in PSP and in PD and provides a useful parameter to differentiate neurodegenerative movement disorders based on imaging examinations. KEY POINTS: • 3D multifrequency MR-elastography reveals diffuse regional changes in brain viscoelasticity in neurodegenerative disorders. • Reduced mesencephalic viscoelasticity separates PD and PSP. • Reduced brain viscoelasticity and brain atrophy as independent hallmarks of neurodegeneration hypothesized.
Entities:
Keywords:
Magnetic resonance elastography, MRE; Mesencephalon; Parkinson’s disease; Progressive supranuclear palsy; Tau protein
Authors: Susan M Resnick; Dzung L Pham; Michael A Kraut; Alan B Zonderman; Christos Davatzikos Journal: J Neurosci Date: 2003-04-15 Impact factor: 6.167
Authors: Andreas Fehlner; Sebastian Hirsch; Martin Weygandt; Thomas Christophel; Eric Barnhill; Mykola Kadobianskyi; Jürgen Braun; Johannes Bernarding; Ralf Lützkendorf; Ingolf Sack; Stefan Hetzer Journal: J Magn Reson Imaging Date: 2016-10-20 Impact factor: 4.813
Authors: Lucy V Hiscox; Curtis L Johnson; Eric Barnhill; Matt D J McGarry; John Huston; Edwin J R van Beek; John M Starr; Neil Roberts Journal: Phys Med Biol Date: 2016-11-15 Impact factor: 3.609
Authors: Arvin Arani; Matthew C Murphy; Kevin J Glaser; Armando Manduca; David S Lake; Scott A Kruse; Clifford R Jack; Richard L Ehman; John Huston Journal: Neuroimage Date: 2015-02-17 Impact factor: 6.556
Authors: Katharina Schregel; Eva Wuerfel; Philippe Garteiser; Ines Gemeinhardt; Timour Prozorovski; Orhan Aktas; Hartmut Merz; Dirk Petersen; Jens Wuerfel; Ralph Sinkus Journal: Proc Natl Acad Sci U S A Date: 2012-04-05 Impact factor: 11.205
Authors: Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan Journal: Mov Disord Date: 2017-05-03 Impact factor: 10.338
Authors: Jonathan M Scott; Arvin Arani; Armando Manduca; Kiaran P McGee; Joshua D Trzasko; John Huston; Richard L Ehman; Matthew C Murphy Journal: Med Image Anal Date: 2020-04-22 Impact factor: 8.545
Authors: Emily Rose Triolo; Oleksandr Khegai; Efe Ozkaya; Nicholas Rossi; Akbar Alipour; Lazar Fleysher; Priti Balchandani; Mehmet Kurt Journal: Curr Protoc Date: 2022-03
Authors: Grace McIlvain; James B Tracy; Charlotte A Chaze; Drew A Petersen; Gabrielle M Villermaux; Henry G Wright; Freeman Miller; Jeremy R Crenshaw; Curtis L Johnson Journal: J Child Neurol Date: 2020-03-23 Impact factor: 1.987
Authors: Stefan Hetzer; Florian Dittmann; Karl Bormann; Sebastian Hirsch; Axel Lipp; Danny Jj Wang; Jürgen Braun; Ingolf Sack Journal: J Cereb Blood Flow Metab Date: 2018-09-05 Impact factor: 6.200
Authors: Faria Sanjana; Peyton L Delgorio; Lucy V Hiscox; Theodore M DeConne; Joshua C Hobson; Matthew L Cohen; Curtis L Johnson; Christopher R Martens Journal: J Cereb Blood Flow Metab Date: 2020-10-26 Impact factor: 6.200
Authors: Lucy V Hiscox; Curtis L Johnson; Matthew D J McGarry; Michael Perrins; Aimee Littlejohn; Edwin J R van Beek; Neil Roberts; John M Starr Journal: Neurobiol Aging Date: 2018-02-06 Impact factor: 4.673